University of New Mexico
Thompson received a BS in pharmacy from the University of New Mexico in 1987 and a PhD in molecular and environmental toxicology from the University of Wisconsin – Madison in 1997.
Thompson’s scientific expertise is in cellular and molecular carcinogenesis. His research is directed toward precision medicine-based considerations for cancer prevention and treatment and he has four issued patents for methods to treat prostate cancer and melanoma. The Thompson laboratory studies molecular pathways in prostate cancer development using human prostate cancer cells in culture and xenograft and transgenic mouse models of prostate cancer. A combination of molecular genetic and biochemical techniques are used to examine androgen-driven pathways and androgen-independent pathways as targets for prostate cancer prevention and treatment. His publications encompass research on endocrine-sensitive cancers, including breast and prostate cancer. The Thompson laboratory developed the Multifunctional Androgen Receptor Screening (MARS) assay, which can rapidly detect both androgen receptor agonists and antagonists.